Vigil Neuroscience, Inc.
VIGLDelisted Aug 5, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001827087
Vigil Neuroscience, Inc. was delisted on Aug 5, 2025; its insiders filed their last Form 4 on Aug 7, 2025; 78 institutions reported holding it in 13F filings for Q2 2025, worth $265.8M in total; no superinvestor held it.
13F holders, Q3 2024
Institutional positions in Vigil Neuroscience, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 52
- −5 vs. Q2 2024
- Shares held
- 27.7M
- +2.00M (+7.8%) vs. Q2 2024
- Total value
- $94.2M
- −$8.67M (−8.4%) vs. Q2 2024
- New holders
- 11
- 12 more added
- Sold out
- 16
- 18 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VIGL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 2 | $4.55K |
| Q2 2025 | 78 | $265.8M |
| Q1 2025 | 50 | $44.5M |
| Q4 2024 | 51 | $38.4M |
| Q3 2024 | 52 | $94.2M |
| Q2 2024 | 58 | $104.5M |
| Q1 2024 | 54 | $90.5M |
| Q4 2023 | 46 | $84.4M |
| Q3 2023 | 45 | $137.7M |
| Q2 2023 | 47 | $242.1M |
| Q1 2023 | 41 | $245.4M |
| Q4 2022 | 37 | $312.3M |
| Q3 2022 | 33 | $222.7M |
| Q2 2022 | 35 | $44.6M |
| Q1 2022 | 47 | $125.1M |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Vigil Neuroscience, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 5,836,874 | $19.8M | 1.84% | 00.0% | Unchanged |
| Northpond Ventures, LLC | 4,214,498 | $14.3M | 32.82% | 00.0% | Unchanged |
| Siren, L.L.C. | 1,991,038 | $6.77M | 0.34% | +1,991,038 | New |
| BVF Inc | 1,813,633 | $6.17M | 0.18% | 00.0% | Unchanged |
| Sphera Funds Management Ltd. | 1,647,604 | $5.60M | 0.92% | −44,562−2.6% | Reduced |
| Point72 Asset Management, L.P. | 1,600,000 | $5.44M | 0.02% | +115,000+7.7% | Added |
| Deep Track Capital, LP | 1,553,996 | $5.28M | 0.17% | +956,781+160.2% | Added |
| Citadel Advisors LLC | 1,442,468 | $4.90M | 0.01% | −6910.0% | Reduced |
| 683 Capital Management, LLC | 1,219,580 | $4.15M | 0.42% | +119,580+10.9% | Added |
| Vanguard Group Inc | 904,731 | $3.08M | 0.00% | +90,000+11.0% | Added |
| StemPoint Capital LP | 743,719 | $2.53M | 0.76% | −693−0.1% | Reduced |
| Ensign Peak Advisors, Inc | 605,536 | $2.06M | 0.00% | +210,420+53.3% | Added |
| Pivotal bioVenture Partners Investment Advisor LLC | 560,595 | $1.91M | 1.13% | 00.0% | Unchanged |
| Rock Springs Capital Management LP | 471,958 | $1.60M | 0.05% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 448,891 | $1.53M | 0.03% | 00.0% | Unchanged |
| BlackRock, Inc. | 422,547 | $1.44M | 0.00% | +422,547 | New |
| ArrowMark Colorado Holdings LLC | 289,460 | $984.2K | 0.01% | 00.0% | Unchanged |
| Millennium Management LLC | 278,756 | $947.8K | 0.00% | −56,051−16.7% | Reduced |
| Standard Life Aberdeen plc | 235,011 | $799.0K | 0.00% | +235,011 | New |
| Geode Capital Management, LLC | 226,083 | $768.8K | 0.00% | +66,712+41.9% | Added |
| Woodline Partners LP | 144,142 | $490.1K | 0.00% | −62,472−30.2% | Reduced |
| Marshall Wace, LLP | 144,042 | $489.7K | 0.00% | +144,042 | New |
| Verition Fund Management LLC | 130,030 | $442.1K | 0.00% | +130,030 | New |
| Walleye Capital LLC | 119,792 | $407.3K | 0.00% | +92,217+334.4% | Added |
| Bridgeway Capital Management, LLC | 105,064 | $357.2K | 0.01% | +25,000+31.2% | Added |
| Two Sigma Investments, LP | 95,084 | $323.3K | 0.00% | +83,019+688.1% | Added |
| Northern Trust Corp | 50,165 | $170.6K | 0.00% | −83,438−62.5% | Reduced |
| Citigroup Inc | 48,383 | $164.5K | 0.00% | +45,972+1,906.8% | Added |
| Renaissance Technologies LLC | 46,000 | $156.4K | 0.00% | −25,500−35.7% | Reduced |
| Barclays PLC | 44,613 | $151.7K | 0.00% | −142−0.3% | Reduced |
| Qube Research & Technologies Ltd | 42,585 | $144.8K | 0.00% | +12,156+39.9% | Added |
| PEAK6 Investments LLC | 41,486 | $141.1K | 0.01% | 00.0% | Unchanged |
| State Street Corp | 40,739 | $138.5K | 0.00% | 00.0% | Unchanged |
| Sherbrooke Park Advisers LLC | 26,329 | $89.5K | 0.02% | +26,329 | New |
| Bank of America Corp | 23,463 | $79.8K | 0.00% | −3,334−12.4% | Reduced |
| ADAR1 Capital Management, LLC | 21,737 | $73.9K | 0.01% | +21,737 | New |
| Two Sigma Advisers, LP | 20,100 | $68.3K | 0.00% | +20,100 | New |
| American Century Companies Inc | 19,970 | $67.9K | 0.00% | +19,970 | New |
| Cubist Systematic Strategies, LLC | 15,762 | $53.6K | 0.00% | +12,109+331.5% | Added |
| Point72 Asia (Singapore) Pte. Ltd. | 11,687 | $39.7K | 0.01% | −10,167−46.5% | Reduced |
| Jump Financial, LLC | 10,000 | $34.0K | 0.00% | +10,000 | New |
| Catalyst Funds Management Pty Ltd | 4,100 | $13.9K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 3,512 | $11.9K | 0.00% | −8,253−70.1% | Reduced |
| FMR LLC | 2,086 | $7.09K | 0.00% | −810−28.0% | Reduced |
| Royal Bank of Canada | 471 | $2.00K | 0.00% | −19,984−97.7% | Reduced |
| JPMorgan Chase & Co | 414 | $1.41K | 0.00% | −8,723−95.5% | Reduced |
| UBS Group AG | 283 | $962 | 0.00% | −4,525−94.1% | Reduced |
| Federated Hermes, Inc. | 198 | $673 | 0.00% | 00.0% | Unchanged |
| Nisa Investment Advisors, LLC | 45 | $153 | 0.00% | −30−40.0% | Reduced |
| Morgan Stanley | 11 | $37 | 0.00% | −19,830−99.9% | Reduced |
| Point72 (DIFC) Ltd | 7 | $24 | 0.00% | −5,499−99.9% | Reduced |
| Gotham Asset Management, LLC | 5,933 | – | – | +5,933 | New |
| Artal Group S.A. | 0 | $0 | 0.00% | −1,828,691−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −401,139−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −62,354−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −48,051−100.0% | Sold out |
| Alpine Global Management, LLC | 0 | $0 | 0.00% | −44,893−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −38,364−100.0% | Sold out |
| Centiva Capital, LP | 0 | $0 | 0.00% | −32,800−100.0% | Sold out |
| Paloma Partners Management Co | 0 | $0 | 0.00% | −16,609−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −10,867−100.0% | Sold out |
| Mirae Asset Global ETFs Holdings Ltd. | 0 | $0 | 0.00% | −8,135−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −6,598−100.0% | Sold out |
| Rhumbline Advisers | 0 | $0 | 0.00% | −2,588−100.0% | Sold out |
| Russell Investments Group, Ltd. | 0 | $0 | 0.00% | −2,029−100.0% | Sold out |
| Macquarie Group Ltd | 0 | $0 | 0.00% | −831−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −140−100.0% | Sold out |
| CWM, LLC | 0 | $0 | 0.00% | −16−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |